InvestorsHub Logo
Followers 521
Posts 24997
Boards Moderated 0
Alias Born 12/31/2009

Re: tombrady12nh post# 113

Monday, 04/03/2017 12:08:49 PM

Monday, April 03, 2017 12:08:49 PM

Post# of 542
Here's an interesting thought....I see from the board you have been here a while, but in 30-minutes of reading here is what I've found.....TTF (the technology used by NVCR) has not been approved by the FDA yet "TTFields are not approved for the treatment of ovarian cancer by the U.S. Food and Drug Administration. The safety and effectiveness of TTFields therapy for ovarian cancer has not been established"

However with 3 now consecutive successful Phase 2 and Phase 3 positive result studies done with this technology/device....can you imagine what NVCR would be if the FDA finally approved the TTF technology for treatments? They now have the technology and data to put pressure on the FDA for TTF Treatment approvals it looks like.

$NVCR unlike a lot of under $10 pharms is not a one-trick pony per say....they have several phase studies in the pipeline and the brain cancer treatment phase 3 study/results yesterday were very positive and encouraging and will gain support now as the news articles state.

I would NOT be surprised now after the results of the 3 studies that something very soon gets Fast Tracked by the FDA.

JMO
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NVCR News